Skip Navigation

JNCI Journal of the National Cancer Institute 2002 94(5):324-326; doi:10.1093/jnci/94.5.324
© 2002 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Garber, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garber, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 94, No. 5, 324-326, March 6, 2002
© 2002 Oxford University Press

NEWS

Battle Over Generic Taxol Concludes, But Controversy Continues

Ken Garber

The long legal battle over Taxol (paclitaxel) that lasted more than 4 years and threatened generic paclitaxel almost to the last moment now appears to be resolved. In late January, Bristol-Myers Squibb and Ivax Pharmaceuticals, the major combatants, reached a settlement, saving Ivax’s cheaper generic version from removal from the market.

Although a third warring party, American BioSciences Inc. (ABI), remains defiant, generic sales of a drug that Bristol marketed exclusively for almost 8 years now seem secure. But a Federal Trade Commission investigation into Bristol’s actions continues, and the saga demonstrates how far drug companies will go to maintain a market monopoly.

Paclitaxel was developed mostly in the public domain by the National Cancer Institute beginning in the 1960s. An NCI-sponsored plant screening program led to the discovery that the bark of the Pacific . . . [Full Text of this Article]

Blocking Generics

Legal Maelstrom

Bristol Backs Off

Changing the Law


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?